For several years, CDISC and Regulatory Data Submission expert Angelo Tinazzi has authored the series, The Good Data Submission Doctor, offering his insight and expertise on data submission and data integration. This collection details some of his most critical insights on clinical data standardization, including:
- From Before to After: Preparing and Concluding Your FDA Data Submission
- In a Virtual Room with the FDA Reviewers
- Watch Out, the FDA Rejection Criteria Are Now in Place
- The Importance of Traceability
- The Integration Dilemma
- More Hidden “Gems”: Raising the Awareness for Additional FDA Data Standards Submission Recommendations
- Regulatory Submissions Support
Click below to read “The Good Data Doctor on Data Submission and Data Integration”:
The Weekend Read series features complimentary publications on a variety of topics on clinical trial design and data science. Subscribe to our weekly newsletter below and never miss a post!
Read more from Perspectives on Enquiry and Evidence:
Sorry no results please clear the filters and try again
The Evolution of Open-Source Initiatives and New Standards Development for the Data Submission of the Future
In the first part of this post, I discussed the ongoing revolution, or maybe I should say evolution, we are living..
Read more
Embracing AI and ML in Medical Devices: FDA’s Total Product Lifecycle-Based Regulatory Framework
Written by Fei Tang, RWE Senior Research Consultant, and Paul Arora, Assistant Professor (Status), Dalla Lana School of..
Read more
Presenting Clinical Data for Regulatory Submission: A Stats Perspective
Data submissions are very regulated, but every drug and drug development are different. Therefore, the data presented..
Read more
